Bryan Johnson takes 30 ml of high-polyphenol extra virgin olive oil daily as a core part of his Blueprint protocol. Here's why high-phenolic EVOO is genuinely longevity-relevant, the brands that meet his criteria, and how to apply the protocol cost-effectively.
Of all the supplements and interventions Bryan Johnson has popularized through his Blueprint project, the one with the strongest underlying evidence base may also be the simplest: 30 ml of high-polyphenol extra virgin olive oil daily, taken straight. The science is real, the cost is reasonable, and the protocol is one of the few "longevity hacks" with substantial randomized trial support.
This article explains why high-phenolic EVOO is the most evidence-supported single component of the Blueprint stack, what specifications matter, the brands that meet the criteria, and how to do this without paying the premium for designer EVOO.
Most supermarket extra virgin olive oils contain modest polyphenol levels — typically 100–250 mg/kg of total polyphenols. The longevity-relevant compounds in EVOO are oleocanthal (anti-inflammatory, mechanism similar to ibuprofen), oleacein (antioxidant, cardiovascular protective), hydroxytyrosol (the most-studied for cardiovascular endpoints), and tyrosol.
The European Food Safety Authority allows a health claim for olive oil polyphenols at intakes of ≥5 mg of hydroxytyrosol and its derivatives per 20 g of olive oil. Most supermarket EVOO doesn't reliably meet this threshold. High-polyphenol EVOO — typically defined as ≥500 mg/kg of total polyphenols — reliably does.
The PREDIMED trial, which randomized roughly 7,500 high-cardiovascular-risk adults to a Mediterranean diet supplemented with EVOO vs a low-fat control diet, showed a 30% reduction in major cardiovascular events over 5 years. The EVOO arm received approximately 50 ml of EVOO per day from a high-quality Spanish source. This is one of the largest, longest randomized controlled trials of any nutritional intervention ever conducted.